Hi noom, I am using NPAT before abnormals. Using adjusted NPAT I calculate the same annual average PE ratio as you.
Whichever way you cut it, earnings are in decline and share price may have further to fall.
I Have been a holder since 2017. At one stage it was my largest holding, fortunately I reduced my exposure after the first downgrade. Nevertheless i am currently sitting on a substantial capital loss, down around 30%. I should have followed my gut and exited completely after the results announcement.
I have lost confidence in management and their ability to turn things around. All I hear is loss of contracts and market share, and shrinking the business. They are making much of the opportunities in data centres, but it represents only 3% of the business and they are a very small player compared to Infratil.
Unlike many others on this forum, I am not looking to add at these levels, rather opportunities to sell and cut my losses.
- Forums
- ASX - By Stock
- SPK
- SP dropping below $4.00 hurts
SPK
spark new zealand limited
Add to My Watchlist
0.00%
!
$2.17

SP dropping below $4.00 hurts, page-147
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.17 |
Change
0.000(0.00%) |
Mkt cap ! $4.099B |
Open | High | Low | Value | Volume |
$2.17 | $2.18 | $2.15 | $1.078M | 497.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
34 | 45254 | $2.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.17 | 19157 | 16 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 47677 | 2.160 |
37 | 156937 | 2.150 |
23 | 302970 | 2.140 |
15 | 82383 | 2.130 |
3 | 223890 | 2.120 |
Price($) | Vol. | No. |
---|---|---|
2.170 | 35295 | 19 |
2.180 | 54131 | 19 |
2.190 | 84066 | 19 |
2.200 | 131402 | 18 |
2.210 | 32314 | 8 |
Last trade - 14.45pm 18/06/2025 (20 minute delay) ? |
Featured News
SPK (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online